Evolus Inc. Common Stock
(NASDAQ:EOLS)
Description
Evolus, Inc., a performance beauty company, provides products in the self-pay aesthetic healthcare market for physicians and their patients in the United States. The company offers products for physicians that are sold to consumers or used in procedures for aesthetic indications, which are not reimbursed by third-party payors. Its products include Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
EOLS Overview
None
Sector |
Health Care |
Industry |
Major Pharmaceuticals |
Previous Close |
$7.0800 |
Previous Close Volume |
457110 |